Cart
sales@molnova.com
Elsulfavirine
CAS No. 868046-19-9
Elsulfavirine ( Elpida; VM-1500 )
Catalog No. M24876 CAS No. 868046-19-9
Elsulfavirine is an HIV-1 infection reverse transcriptase inhibitor. It is a new anti-HIV drug.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 177 | In Stock |
|
| 10MG | 290 | In Stock |
|
| 25MG | 492 | In Stock |
|
| 50MG | 709 | In Stock |
|
| 100MG | 972 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameElsulfavirine
-
NoteResearch use only, not for human use.
-
Brief DescriptionElsulfavirine is an HIV-1 infection reverse transcriptase inhibitor. It is a new anti-HIV drug.
-
DescriptionElsulfavirine is an HIV-1 infection reverse transcriptase inhibitor. It is a new anti-HIV drug.
-
SynonymsElpida; VM-1500
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV-1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number868046-19-9
-
Formula Weight629.3
-
Molecular FormulaC24H17BrCl2FN3O5S
-
Purity>98% (HPLC)
-
SolubilityDMSO:60 mg/mL?(95.35 mM;?Need ultrasonic)
-
SMILESCCC(NS(c(cc1)cc(Cl)c1NC(Cc(ccc(Br)c1Oc2cc(Cl)cc(C#N)c2)c1F)=O)(=O)=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Rai MA, et al. Emerging reverse transcriptase inhibitors for HIV-1 infection. Expert Opin Emerg Drugs. 2018 Jun;23(2):149-157.
molnova catalog
related products
-
14-Dicaffeoylquinic ...
14-Dicaffeoylquinic acid has antioxidant activity.14-Dicaffeoylquinic acid is a potent and highly selective class of HIV-1 integrase inhibitors inhibitsHIV-1 replication in MT-2 cell culture at non-toxic concentrations.
-
Ditiocarb sodium
Ditiocarb sodium (Sodium diethyldithiocarbamate) is an accelerator of the rate of copper cementation. Sodium diethyldithiocarbamate reduces the incidence of HIV infection.
-
YIR-821
YIR-821 is a small-molecule CD4 mimic that acts as a highly potent HIV entry inhibitor with IC50 of 2.8 uM against YTA48P virus with no significant cytotoxicity (CC50>200 uM).
